Clinical TrialsSearch results
Number of results: 1089
Recruiting
- [M24-305]Atogepant for the Acute Treatment of Migraine
- Migraine
- Otani Tetsuya
- 2024-04-03
Recruiting
- A clinical trial of the effect of remimazolam on postoperative ECG in gynecologic laparotomy
- Patients scheduled for gynecologic laparotomy
- Hori Kotaro
- 2022-07-26
Recruiting
- A Japanese prospective observational study to assess a correlation between pre-surgical analysis of ctDNA and post-surgical pathological upstaging in patients with resectable clinical stage IA-IB Non-Small Cell Lung Cancer (NSCLC)
- Resectable clinical stage IA-IB Non-Small Cell Lung Cancer(NSCLC)
- Hibi Kazushige
- 2024-03-06
Recruiting
- A multicenter randomized controlled trial of the efficacy of anti-adhesion barrier in laparoscopic rectal amputation
- rectal cancer, rectal neuroendocrine tumor
- Uemura Mamoru
- 2024-05-20
Recruiting
- A Multicenter Retrospective Observational Study to Investigate the Epidemiology and Recurrence and Prognosis in Patients Undergoing Surgery for Lung Adenocarcinoma Harboring ALK Rearrangement
- Lung adenocarcinoma
- Tsutani Yasuhiro
- 2024-06-10
Recruiting
- A multicenter single-arm P2 to evaluate safety and efficacy of the total neoadjuvant therapy for cT2 rectal cancer.
- rectal cancer
- Uemura Mamoru
- 2023-04-13
Recruiting
- A multicenter, pivotal study to demonstrate non-inferiority of Cyt-006 compared to Seprafilm in patients with primary rectal cancer and temporal colostomy underwent laparoscopic surgery
- primary rectal cancer
- Horii Yoshihiro
- 2022-08-10
Recruiting
- A Multicenter, Randomized, Parallel-group, Double-blind,Two-arm Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared With Placebo in Male and Female Participants 18 to 70 Years of Age Inclusive With Systemic Sclerosis
- Systemic Sclerosis, Scleroderma
- Ageishi Yuji
- 2023-11-11
Recruiting
- A Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of TIN816 in Japanese healthy participants
- Healthy participants
- Hirano Takamitsu
- 2023-09-27
Recruiting
- A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD-L1 high NSCLC
- Non-small-cell lung cancer
- Ishibashi Hideyasu
- 2024-06-04